Isaacson Erin, Woolford Susan J, Dobson Cheyney, McCaffery Harlan, Rosen Monica W
Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA.
Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA.
J Assist Reprod Genet. 2025 Jul 17. doi: 10.1007/s10815-025-03581-8.
This study aimed to determine if clinicians who provide potential gonadotoxic medications refer pediatric patients differently for a fertility preservation (FP) consultation based on race, ethnicity, socioeconomic status, or preferred language of the patient.
This was a retrospective cohort study at a single tertiary care center. Patients assigned female at birth aged 5-21 years who underwent treatments considered medium to high risk for gonadotoxicity from 2017 to 2022 were included. Patients were excluded if they were referred from outside institutions already undergoing treatment or if they had a diagnosis of hemophagocytic lymphohistiocytosis. The primary outcome in the study was the presence of a referral to the FP team for patients undergoing gonadotoxic therapy.
The total cohort included 236 patients, 122 (51.6%) of whom were referred to the fertility preservation team. There was no significant difference in patients' racial or ethnic backgrounds between referred and not referred. Those not referred were significantly younger (13.4 vs 16.3, P < .001) and less likely to speak English (7.1% vs .8%, P = .013). Patients less than 10 years of age made up 36.8% of those not referred, and only 1.6% of those referred. There was no difference in average Area Deprivation Index score between those referred and not (4.4 vs 5.0, P = .16), and referrals did not differ significantly between patients of low, medium, or high socioeconomic status (P = .28).
Only half of appropriate patients were referred for fertility preservation counseling, and non-English speakers were significantly less likely to be referred, demonstrating a substantial need to address underlying referral disparities.
本研究旨在确定提供潜在性腺毒性药物的临床医生是否会根据患者的种族、族裔、社会经济地位或首选语言,对儿科患者进行不同的生育力保存(FP)咨询转诊。
这是一项在单一三级医疗中心进行的回顾性队列研究。纳入了2017年至2022年间接受被认为性腺毒性风险为中到高的治疗、出生时被指定为女性的5至21岁患者。如果患者是从外部机构转诊而来且已在接受治疗,或者被诊断为噬血细胞性淋巴组织细胞增生症,则将其排除。该研究的主要结局是接受性腺毒性治疗的患者被转诊至FP团队的情况。
整个队列包括236名患者,其中122名(51.6%)被转诊至生育力保存团队。转诊患者和未转诊患者在种族或族裔背景上没有显著差异。未被转诊的患者明显更年轻(13.4岁对16.3岁,P<0.001),且说英语的可能性更小(7.1%对0.8%,P = 0.013)。10岁以下的患者在未被转诊的患者中占36.8%,而在被转诊的患者中仅占1.6%。转诊患者和未转诊患者的平均地区贫困指数得分没有差异(4.4对5.0,P = 0.16),低、中、高社会经济地位患者之间的转诊情况也没有显著差异(P = 0.28)。
只有一半的合适患者被转诊进行生育力保存咨询,非英语使用者被转诊的可能性显著更低,这表明迫切需要解决潜在的转诊差异问题。